| Name | Title | Contact Details |
|---|---|---|
Julie Person |
Senior Vice President of Human Resources | Profile |
David Nagler |
Senior Vice President of Human Resources | Profile |
Libra Therapeutics is focused on developing novel disease-modifying therapeutics that can restore the cellular balance disrupted in neurodegenerative diseases.
Tessera Therapeutics is pioneering GENE WRITING technology, which consists of multiple technology platforms designed to offer scientists and clinicians the ability to write therapeutic messages into the human genome, thereby curing diseases at their source. The GENE WRITING platform allows the correction of single nucleotides, the deletion or insertion of short sequences of DNA, and the writing of entire genes into the genome, offering the potential for a new category of genetic medicines with broad applications both in vivo and ex vivo. Tessera Therapeutics was founded by Flagship Pioneering in 2018, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
Pointilliste is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Threshold Pharmaceuticals, Inc. is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Centrillion Biosciences is a leading genomic and bioinformatics solution provider.